» Articles » PMID: 32117072

The Potential Role of Growth Hormone on the Endometrium in Assisted Reproductive Technology

Overview
Specialty Endocrinology
Date 2020 Mar 3
PMID 32117072
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Growth hormone (GH) has been considered as an adjuvant treatment in human assisted reproductive technology (ART) for several years. Its action was largely attributed to an improvement of ovarian function and less emphasis was paid to its role in the uterus. However, there is increasing evidence that GH and its receptors are expressed and have actions in the endometrium and may play an important role in modifying endometrial receptivity. Thus, in this review, we firstly describe the existence of GH receptors in endometrium and then summarize the effects of GH on the endometrium in clinical situations and the underlying mechanisms of GH in the regulation of endometrial receptivity. Finally, we briefly review the potential risks of GH in ART and consider rationalized use of GH treatment in ART.

Citing Articles

Sexual dimorphism in the effects of maternal adipose tissue growth hormone receptor deficiency on offspring metabolic health.

Ran L, Wang X, Ma R, Wang H, Wu Y, Yu Z Biol Sex Differ. 2024; 15(1):98.

PMID: 39623508 PMC: 11610217. DOI: 10.1186/s13293-024-00676-2.


Atosiban interacts with growth hormones as adjuvants in frozen-thawed embryo transfer cycles.

Chen H, Cai J, Sun X, Liu L, Liu Z, Gao P Front Endocrinol (Lausanne). 2024; 15:1380778.

PMID: 38841302 PMC: 11150816. DOI: 10.3389/fendo.2024.1380778.


The Impact of Growth Hormone Co-Treatment Duration on Outcomes in IVF/ICSI Cycles Among Poor Ovarian Responders.

Mohammadshirazi Z, Alyasin A, Agha Hosseini M, Hazari V J Reprod Infertil. 2024; 24(4):279-286.

PMID: 38164424 PMC: 10757689. DOI: 10.18502/jri.v24i4.14155.


Metabolic hormones are integral regulators of female reproductive health and function.

Athar F, Karmani M, Templeman N Biosci Rep. 2023; 44(1).

PMID: 38131197 PMC: 10830447. DOI: 10.1042/BSR20231916.


Effect of growth hormone cotreatment in sub-fertile women ≥ 40 years: A Meta-analysis.

Elkalyoubi M, Schindler L, Zaheer H Reprod Fertil. 2023; .

PMID: 36807147 PMC: 10083671. DOI: 10.1530/RAF-22-0107.


References
1.
Zhao J, Zhang Q, Wang Y, Li Y . Endometrial pattern, thickness and growth in predicting pregnancy outcome following 3319 IVF cycle. Reprod Biomed Online. 2014; 29(3):291-8. DOI: 10.1016/j.rbmo.2014.05.011. View

2.
Arce H, Velilla E, Lopez-Teijon M . Association between endometrial thickness in oocyte donation cycles and pregnancy success rates. Reprod Fertil Dev. 2015; . DOI: 10.1071/RD14459. View

3.
Rhoads M, Meyer J, Kolath S, Lamberson W, Lucy M . Growth hormone receptor, insulin-like growth factor (IGF)-1, and IGF-binding protein-2 expression in the reproductive tissues of early postpartum dairy cows. J Dairy Sci. 2008; 91(5):1802-13. DOI: 10.3168/jds.2007-0664. View

4.
Molitch M, Clemmons D, Malozowski S, Merriam G, Vance M . Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(6):1587-609. DOI: 10.1210/jc.2011-0179. View

5.
Santos J, Juchem S, Cerri R, Galvao K, Chebel R, Thatcher W . Effect of bST and reproductive management on reproductive performance of Holstein dairy cows. J Dairy Sci. 2004; 87(4):868-81. DOI: 10.3168/jds.S0022-0302(04)73231-2. View